Periodontal health status, Porphyromonas gingivalis and anti-cyclic citrullinated peptide antibodies among rheumatoid arthritis patients

被引:0
|
作者
Jiun, Tan Wan [1 ]
Taib, Haslina [2 ,6 ]
Mohamad, Wan Majdiah Wan [3 ]
Mohamad, Suharni [4 ]
Ghazali, Wan Syamimee Wan [5 ]
机构
[1] Klinik Pergigian Cahaya Suria, Unit Periodontik, 7 Jalan 3-12, Kuala Lumpur 50050, Malaysia
[2] Univ Sains Malaysia, Sch Dent Sci, Periodont Unit, Hlth Campus, Kota Baharu 16150, Kelantan, Malaysia
[3] Hlth Campus Univ Sains Malaysia, Sch Dent Sci, Immunol Unit, Kota Baharu 16150, Kelantan, Malaysia
[4] Univ Sains Malaysia, Sch Dent Sci, Microbiol Unit, Hlth Campus, Kota Baharu 16150, Kelantan, Malaysia
[5] Univ Sains Malaysia, Sch Med Sci, Med Dept, Hlth Campus, Kota Baharu 16150, Kelantan, Malaysia
[6] Univ Sains Malaysia, Hosp Univ Sains Malaysia, Sch Dent Sci, Hlth Campus, Kota Baharu 16150, Kelantan, Malaysia
关键词
Porphyromonas gingivalis; Periodontitis; Rheumatoid arthritis; Anti -cyclic citrullinated peptide; PORPHYROMONAS-GINGIVALIS; TANNERELLA-FORSYTHIA; TREPONEMA-DENTICOLA; DISEASE; ACTINOMYCETEMCOMITANS; ASSOCIATION; PARAMETERS; SEVERITY;
D O I
10.1016/j.intimp.2023.110940
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Porphyromonas gingivalis (P. gingivalis) is the primary periodontal pathogen involved in protein citrullination, which triggers the production of anti-cyclic citrullinated peptide (anti-CCP) antibodies, exacerbating rheumatoid arthritis (RA). This study aims to evaluate the amount of P. gingivalis and its association with anti-CCP antibodies in RA patients with periodontitis. This cross-sectional study involves 100 RA patients with a mean age of 52.36 (SD 13.90) years. Smokers and patients with other uncontrolled systemic diseases were excluded. Disease Ac-tivity Score-28 (DAS-28) was used to determine RA disease severity. Periodontal parameters were examined to determine periodontal status. Subsequently, plaque samples were collected from the subgingival periodontal pocket for assessment of P. gingivalis bacterial load using the loop-mediated isothermal amplification method. Blood samples (5 ml) were obtained from all participants to analyse anti-CCP antibody levels. Data was analysed by using SPSS version 24.0. Most participants were female (85.0%) and had low RA disease severity (62%). The mean RA disease duration was 7.77 (SD 6.3) years, with a mean DAS-28 of 3.17 (SD 1.0). Forty-seven per cent of participants had periodontitis, but all periodontal parameters were not associated with RA disease activity (P = 0.38). P. gingivalis bacterial load ranged from 10 to 109 copies/mu l. Fifty-five per cent of the collected samples showed positive anti-CCP antibody levels, but no significant association was observed with the P. gingivalis bacterial load (P = 0.58). Considering the study's limitations, although periodontitis is prevalent among RA patients, there is a lack of association between P. gingivalis bacterial load and anti-CCP antibody levels, which should be investigated further.
引用
收藏
页数:6
相关论文
共 50 条
  • [21] Evaluation of Anti-Mutated Citrullinated Vimentin Antibodies, Anti-Cyclic Citrullinated Peptide Antibodies and Rheumatoid Factor in Omani Patients with Rheumatoid Arthritis
    Al-Shukaili, Ahmed
    Al-Ghafri, Saif
    Al-Marhoobi, Safia
    Alkaabi, Juma
    INTERNATIONAL JOURNAL OF RHEUMATOLOGY, 2012, 2012
  • [22] Ocular manifestations of rheumatoid arthritis and their correlation with anti-cyclic citrullinated peptide antibodies
    Vignesh, Ammapati Paul Pandian
    Srinivasan, Renuka
    CLINICAL OPHTHALMOLOGY, 2015, 9 : 393 - 397
  • [23] Clinical Significance of Anti-Cyclic Citrullinated Peptide Antibodies and IgM Rheumatoid Factor in Rheumatoid Arthritis Patients
    Seo, Soyeon
    Lee, Jisoo
    Kang, Eun-Suk
    EWHA MEDICAL JOURNAL, 2005, 28 (02): : 87 - 92
  • [24] Anti-cyclic citrullinated peptide antibodies and rheumatoid factor in rheumatoid arthritis patients and relatives from Brazil
    Goeldner, Isabela
    Skare, Thelma L.
    Reason, Iara T. de Messias
    Nisihara, Renato M.
    Silva, Marilia B.
    da Rosa Utiyama, Shirley R.
    RHEUMATOLOGY, 2010, 49 (08) : 1590 - 1593
  • [25] Discriminative and diagnostic value of anti-cyclic citrullinated peptide antibodies in Iranian patients with rheumatoid arthritis
    Jamileh Moghimi
    Raheb Ghorbani
    Farnaz Hasani
    Mehrdad Sheikhvatan
    Rheumatology International, 2013, 33 : 601 - 605
  • [26] Anti-Cyclic Citrullinated Peptide Antibodies in Patients with Juvenile Idiopathic Arthritis
    Habib, H. M.
    Mosaad, Y. M.
    Youssef, H. M.
    IMMUNOLOGICAL INVESTIGATIONS, 2008, 37 (08) : 849 - 857
  • [27] Discriminative and diagnostic value of anti-cyclic citrullinated peptide antibodies in Iranian patients with rheumatoid arthritis
    Moghimi, Jamileh
    Ghorbani, Raheb
    Hasani, Farnaz
    Sheikhvatan, Mehrdad
    RHEUMATOLOGY INTERNATIONAL, 2013, 33 (03) : 601 - 605
  • [28] Anti-cyclic citrullinated peptide antibodies in psoriasis patients without arthritis
    Böckelmann, R
    Gollnick, H
    Bonnekoh, B
    ARTHRITIS AND RHEUMATISM, 2006, 54 (05): : 1701 - 1702
  • [29] Anti-cyclic citrullinated peptide antibodies in patients with juvenile idiopathic arthritis
    Hromadnikova, I
    Stechova, K
    Vavrincova, P
    Hridelova, D
    Houbova, B
    Voslarova, S
    Nekvasilova, H
    Vavrinec, J
    AUTOIMMUNITY, 2002, 35 (06) : 397 - 401
  • [30] Effect of infliximab therapy on anti-cyclic citrullinated peptide antibodies levels in patients with rheumatoid arthritis
    Kyriazis, NC
    Papalopoulou, M
    Balla, M
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 172 - +